Metraipolis › archive › dc_8a9a25d81efb

18β-glycyrrhetinic acid inhibits lung adenocarcinoma progression by targeting the MET/AKT signaling axis — Europe PMC PMID:42698770

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42698770
DOI
10.3389/fcell.2026.1752632
License (as archived)
solo-consultazione
Archived
2026-10-07T21:37:54.418Z
SHA-256 of the archived text
ba879c343b0b3e699d0071261684ae2b9e8e00ff199e982ea2da92583d3840ab
Stable URL of this page
https://metraipolis.com/documento/dc_8a9a25d81efb

How to cite

18β-glycyrrhetinic acid inhibits lung adenocarcinoma progression by targeting the MET/AKT signaling axis — Europe PMC PMID:42698770 — Europe PMC (en), https://europepmc.org/article/MED/42698770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a9a25d81efb (Metraipolis archive dc_8a9a25d81efb, sha256 ba879c343b0b3e699d0071261684ae2b9e8e00ff199e982ea2da92583d3840ab)
BibTeX
@misc{dc8a9a25d81efb,
  title = {18β-glycyrrhetinic acid inhibits lung adenocarcinoma progression by targeting the MET/AKT signaling axis — Europe PMC PMID:42698770},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42698770},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a9a25d81efb; sha256 ba879c343b0b3e699d0071261684ae2b9e8e00ff199e982ea2da92583d3840ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42698770. Agents can read the archived copy with the MCP tool read_document.